Drreddys Laboratories | RDY - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bayer EUR -1.16B 735M 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Cipla INR 11.69B 6.85B 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Drreddys Laboratories INR 15.43B 1.96B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Novartis USD 4.64B 445M 2025-12
Pacira USD 9.52M 11.45M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 69.13M 7.35M 2025-09
Richter Gedeon HUF 78.56B 32.66B 2024-12
Sun Pharmaceuticals INR 41.68B 9.95B 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12